These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 34072627

  • 1. Dual Mechanisms of Metabolism and Gene Expression of the CCRF-CEM Leukemia Cells under Glucocorticoid Treatment.
    Lambrou GI, Karakonstantakis T, Vlahopoulos S, Zaravinos A.
    Int J Mol Sci; 2021 May 31; 22(11):. PubMed ID: 34072627
    [Abstract] [Full Text] [Related]

  • 2. Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines.
    Nuessler V, Stötzer O, Gullis E, Pelka-Fleischer R, Pogrebniak A, Gieseler F, Wilmanns W.
    Leukemia; 1999 Nov 31; 13(11):1864-72. PubMed ID: 10557064
    [Abstract] [Full Text] [Related]

  • 3. Expression, regulation and function of phosphofructo-kinase/fructose-biphosphatases (PFKFBs) in glucocorticoid-induced apoptosis of acute lymphoblastic leukemia cells.
    Carlet M, Janjetovic K, Rainer J, Schmidt S, Panzer-Grümayer R, Mann G, Prelog M, Meister B, Ploner C, Kofler R.
    BMC Cancer; 2010 Nov 23; 10():638. PubMed ID: 21092265
    [Abstract] [Full Text] [Related]

  • 4. Glucocorticoid-receptor-gene defects and resistance to glucocorticoid-induced apoptosis in human leukemic cell lines.
    Hala M, Hartmann BL, Böck G, Geley S, Kofler R.
    Int J Cancer; 1996 Nov 27; 68(5):663-8. PubMed ID: 8938150
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells.
    Hulleman E, Kazemier KM, Holleman A, VanderWeele DJ, Rudin CM, Broekhuis MJ, Evans WE, Pieters R, Den Boer ML.
    Blood; 2009 Feb 26; 113(9):2014-21. PubMed ID: 18978206
    [Abstract] [Full Text] [Related]

  • 6. Elucidating the identity of resistance mechanisms to prednisolone exposure in acute lymphoblastic leukemia cells through transcriptomic analysis: A computational approach.
    Sifakis EG, Lambrou GI, Prentza A, Vlahopoulos S, Koutsouris D, Tzortzatou-Stathopoulou F, Chatziioannou AA.
    J Clin Bioinforma; 2011 Dec 20; 1():36. PubMed ID: 22185641
    [Abstract] [Full Text] [Related]

  • 7. PLZF/ZBTB16, a glucocorticoid response gene in acute lymphoblastic leukemia, interferes with glucocorticoid-induced apoptosis.
    Wasim M, Carlet M, Mansha M, Greil R, Ploner C, Trockenbacher A, Rainer J, Kofler R.
    J Steroid Biochem Mol Biol; 2010 Jun 20; 120(4-5):218-27. PubMed ID: 20435142
    [Abstract] [Full Text] [Related]

  • 8. Methadone hydrochloride and leukemia cells: Effects on cell viability, DNA fragmentation and apoptotic proteins expression level.
    Kua VMD, Rasul A, Sreenivasan S, Rasool B, Younis T, Lai NS.
    Pak J Pharm Sci; 2019 Jul 20; 32(4(Supplementary)):1797-1803. PubMed ID: 31680075
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytes. Phenothiazines and leukemia.
    Zhelev Z, Ohba H, Bakalova R, Hadjimitova V, Ishikawa M, Shinohara Y, Baba Y.
    Cancer Chemother Pharmacol; 2004 Mar 20; 53(3):267-75. PubMed ID: 14663628
    [Abstract] [Full Text] [Related]

  • 13. Sequential gene regulatory events leading to glucocorticoid-evoked apoptosis of CEM human leukemic cells:interactions of MAPK, MYC and glucocorticoid pathways.
    Webb MS, Miller AL, Howard TL, Johnson BH, Chumakov S, Fofanov Y, Nguyen-Vu T, Lin CY, Thompson EB.
    Mol Cell Endocrinol; 2018 Aug 15; 471():118-130. PubMed ID: 29596968
    [Abstract] [Full Text] [Related]

  • 14. Prednisolone exerts late mitogenic and biphasic effects on resistant acute lymphoblastic leukemia cells: Relation to early gene expression.
    Lambrou GI, Vlahopoulos S, Papathanasiou C, Papanikolaou M, Karpusas M, Zoumakis E, Tzortzatou-Stathopoulou F.
    Leuk Res; 2009 Dec 15; 33(12):1684-95. PubMed ID: 19450877
    [Abstract] [Full Text] [Related]

  • 15. The role of tumor suppressor of resveratrol and prednisolone by downregulation of YKL-40 expression in CCRF-CEM cell line.
    Zadi Heydarabad M, Baharaghdam S, Azimi A, Mohammadi H, Eivazi Ziaei J, Yazdanpanah B, Zak MS, Farahani ME, Dohrabpour A, Partash N, Talebi M.
    J Cell Biochem; 2019 Mar 15; 120(3):3773-3779. PubMed ID: 30426549
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Carboxypeptidase G2 enhances trimetrexate cytotoxicity in CCRF-CEM cell lines sensitive and resistant to methotrexate.
    Romanini A, Chou TC, Bertino JR.
    Adv Enzyme Regul; 1989 Mar 15; 28():323-33. PubMed ID: 2533849
    [Abstract] [Full Text] [Related]

  • 18. Genomic and transcriptomic profiling of resistant CEM/ADR-5000 and sensitive CCRF-CEM leukaemia cells for unravelling the full complexity of multi-factorial multidrug resistance.
    Kadioglu O, Cao J, Kosyakova N, Mrasek K, Liehr T, Efferth T.
    Sci Rep; 2016 Nov 08; 6():36754. PubMed ID: 27824156
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: a role for MARCKS in acquired resistance to proteasome inhibitors.
    Franke NE, Kaspers GL, Assaraf YG, van Meerloo J, Niewerth D, Kessler FL, Poddighe PJ, Kole J, Smeets SJ, Ylstra B, Bi C, Chng WJ, Horton TM, Menezes RX, Musters RJ, Zweegman S, Jansen G, Cloos J.
    Oncotarget; 2016 Nov 15; 7(46):74779-74796. PubMed ID: 27542283
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.